Correlation Between BeiGene and Arrowhead Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both BeiGene and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BeiGene and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BeiGene and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on BeiGene and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BeiGene with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BeiGene and Arrowhead Pharmaceuticals.

Diversification Opportunities for BeiGene and Arrowhead Pharmaceuticals

-0.46

Correlation Coefficient

BeiGene  Arrowhead Pharmaceuticals

Very good diversification

The 3 months correlation between BeiGene and Arrowhead is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding BeiGene and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and BeiGene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BeiGene are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of BeiGene i.e., BeiGene and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between BeiGene and Arrowhead Pharmaceuticals

Given the investment horizon of 90 days BeiGene is expected to generate 1.73 times less return on investment than Arrowhead Pharmaceuticals. But when comparing it to its historical volatility, BeiGene is 1.76 times less risky than Arrowhead Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  2,291  in Arrowhead Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  324.00  from holding Arrowhead Pharmaceuticals or generate 14.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

BeiGene  vs.  Arrowhead Pharmaceuticals

BeiGene

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in BeiGene are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, BeiGene may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BeiGene and Arrowhead Pharmaceuticals

The main advantage of trading using opposite BeiGene and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BeiGene position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.

The idea behind BeiGene and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.